Sarah Schram

Stock Analyst at William Blair

(n/a)
# 4,656
Out of 5,006 analysts
1
Total ratings
n/a
Success rate
-30.29%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sarah Schram

Denali Therapeutics
Jan 3, 2025
Initiates: Outperform
Price Target: n/a
Current: $15.42
Upside: -